Cutaneous manifestations associated with SARS-CoV-2: an emerging topic in a pandemic era

Luís, Helena; Barros, Carolina; André, Diogo; Malheiro, Alexandra

http://hdl.handle.net/10400.26/37616

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
2021-Cutaneous manifestations associated with SARS-COV-2.pdf		1.53 MB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year-old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared.

Keywords

SARS-CoV-2- cutaneous manifestations hydroxychloroquine COVID-19-Treatment treatment recommendations Medeira Island Região Autónoma da Madeira diffuse urticarial rash oral citirizine